Spire Healthcare Group Aktie
| 2,66EUR | -0,04EUR | -1,48% |
WKN DE: A117ZX / ISIN: GB00BNLPYF73
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 11 943 | 12 318 | 12 889 | 13 236 | 15 703 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,08 | 0,09 | 0,09 | 0,10 | 0,10 |
Bilanz (in Mio. GBP) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 250 | 342 | 219 | 220 | 224 |
| Summe Anlagevermögen | 1 855 | 1 895 | 1 941 | 2 069 | 2 119 |
| Summe Aktiva | 2 105 | 2 237 | 2 160 | 2 288 | 2 343 |
Bilanz (in Mio. GBP) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 1 398 | 1 533 | 1 435 | 1 550 | 1 597 |
| Summe Eigenkapital | 707 | 705 | 725 | 738 | 746 |
| Summe Passiva | 2 105 | 2 237 | 2 160 | 2 288 | 2 343 |
Adresse
| 3 Dorset Rise, EC4Y 8EN London | |
| Telefon | +44 (20) 7427-9000 |
| Fax | +44 (20) 7427-9001 |
| Internet | http://www.spirehealthcare.com |
Management
|
Amie Gramlick
Director-Investor Relations |
|
Antony Mannion
Director-Strategy & Investor Relations |
|
C. A. Ronnie van der Merwe
Non-Executive Director |
|
Cathy Cale
Group Director-Medical |
|
Clifford Shearman
Independent Non-Executive Director |
|
David Sloman
Non-Independent Non-Executive Director |
|
Debra J. White
Senior Independent Director |
|
Harbant Samra
Chief Financial Officer & Executive Director |
|
Ian Michael Cheshire
Non-Executive Chairman |
|
Jenny Kay
Independent Non-Executive Director |
|
Jill Dawn Anderson
Independent Non-Executive Director |
|
John Forrest
Chief Operating Officer |
|
Justinian Joseph Ash
Chief Executive Officer & Executive Director |
|
Lisa Grant
Chief Nurse & Group Clinical Director |
|
Mantraraj Dipak Budhdev
Secretary & General Counsel |
|
Natalie Anna Ceeney
Independent Non-Executive Director |
|
Paula Bobbett
Independent Non-Executive Director |
|
Peter James Corfield
Chief Commercial Officer |
|
Rachel King
Group Director-People |